Abivax (ABVX) Change in Receivables (2024 - 2026)

Abivax's Change in Receivables history runs 3 years deep, the most recent figure standing at -$4.1 million for Q1 2026.

• In Q1 2026, Change in Receivables fell 79.44% year-over-year to -$4.1 million; the TTM figure through Mar 2026 stood at $6.5 million (up 95.03% YoY), while the FY2025 annual figure was $8.2 million, up 67.09% from the prior year.
• Change in Receivables was -$4.1 million for Q1 2026 at Abivax, down from $10.9 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $10.9 million in Q4 2025 to a low of -$5.4 million in Q3 2025.
• Historically, Change in Receivables has averaged $1.0 million across 3 years, with a median of -$735466.9 in 2024.
• Biggest YoY gain for Change in Receivables was 215.48% in 2025; the steepest drop was 209.07% in 2025.
• A 3-year view of Change in Receivables shows it stood at $3.4 million in 2024, then soared by 215.48% to $10.9 million in 2025, then sank by 137.5% to -$4.1 million in 2026.
• The last three Change in Receivables figures came in at -$4.1 million (Q1 2026), $10.9 million (Q4 2025), and -$5.4 million (Q3 2025), per Business Quant data.